No description available.

No description available.

Limbal stem cells maintain the corneal epithelium through a process of clonal growth and ordered migration. In X-inactivation mosaic female mice, that express LacZ from one of their X-chromosomes, random clumps of LacZ-positive cells are seen in the cornea at 3-6 weeks of life. This pattern resolves between 6-10 weeks forming radial stripes thought to represent chords of clonally related, inwardly migrating cells. By measuring the number and width of stripes and correcting for the effects of different proportions of LacZ-positive cells, an estimate of the number of coherent stem cell clones maintaining the tissue can be derived. Analysis at 5 ages demonstrated that the estimated number of coherent stem cell clones is reduced from ~100 at 15 weeks to ~50 at 39 weeks and is then stable at least until 52 weeks. An automated method was developed using image analysis software to analyse these striping patterns. This method produced results that did not differ significantly from the above. The dosage of the transcription factor Pax6 is crucial for normal eye development. In Pax6 heterozygous animals the estimated number of coherent stem cell clones is reduced to ~50 at 15 weeks with no further reduction up to 30 weeks. Mice hemizygous for the PAX77 transgene over-express human PAX6. In PAX77 hemizygous X-inactivation mosaics, estimated clone number was similarly reduced to ~50 with no further decline. Mice heterozygous for both Gli3 and Pax6 have a distinct striping phenotype, highlighted by an increase in coherent clones. When the corneal epithelium is injured the surrounding epithelial cells migrate along the corneal stroma to cover the wound. X-gal staining of healed, centrally wounded X-inactivation eyes reveals that striping patterns are reconstituted during wound healing in ex-vivo culture. In GFP mosaics the healing process can be imaged using time-lapse confocal microscopy. This technique demonstrated that clones remain contiguous throughout their migration. Healing of peripheral wounds was observed to form de-novo whorling patterns, revealing that basal cells in the epithelium can migrate both away from and towards the limbal region.

De par son rôle dans de nombreuses fonctions biologiques, la vitamine A est une molécule majeure et cruciale du développement embryonnaire à l’âge adulte. Celle-ci est aussi, à l’heure actuelle, déjà largement utilisée comme agent thérapeutique pour de nombreuses pathologies affectant principalement la peau et les yeux (cancer, acné, psoriasis,brûlures oculaires) et certains cancers. Son action pro-cicatrisante - bien que largement étudiée grâce à de nombreux modèles humains et animaux - reste encore aujourd’hui mal caractérisée quant aux mécanismes d’action moléculaire (régulation de gènes) et cellulaire(migration, prolifération…) qu’elle utilise.Dans le but d’améliorer et de mieux maîtriser l’utilisation de la vitamine A dans le traitement de lésions telles que les brûlures oculaires, ce travail visait d’une part, à étudier, plus en détail,l’effet de l’acide tout-trans rétinoïque ou ATRA - dérivé le plus actif - sur la cicatrisation de ’épithélium cornéen en utilisant un modèle in vivo de brûlures cornéennes par base chez la souris. Son but était également de déterminer par quels processus cellulaires, l’ATRA agit, en utilisant cette fois-ci un modèle in vitro (cellules épithéliales cornéennes humaines). Enfin,nous nous sommes intéressés à la régulation de gènes cibles par l’ATRA au niveau de la sphère oculaire, connus pour être impliqués dans la dynamique de la MEC.Ainsi, nous avons démontré que l’ATRA permettait la cicatrisation de l’épithélium cornéen en agissant principalement sur la migration cellulaire. Puis nous avons identifié un gène :LOXL4 - membre de la famille des lysyl oxydases - dont l’expression est induite par l’ATRA,et nous avons prouvé que son rôle était essentiel dans la cicatrisation cornéenne, décrivant ainsi pour la première fois un lien génique direct et protéique entre la vitamine A, substance active et son action clinique pro-cicatrisante. / Because of its role in many biological functions, Vitamin A is a major and crucialmolecule from development to adulthood. Currently, it is largely used as therapeutic agent inseveral eye or skin pathologies (acne, psoriasis, ocular burns) and cancers. Its pro-healingproperties have been largely studied in human and animal models but molecular (generegulations) and cellular (migration, proliferation…) mechanisms of the vitamin A actionhave to be more detailed.In order to better improve and control its use in the treatment of lesions such as ocular burns,this work aimed to study, more in details, the effects of atRA (all-trans-retinoic acid), activederivative form of vitamin A, on corneal epithelium healing using an in vivo model of alkaliocular burns in mouse and then, to determine by which cellular process atRA acts, by usingthis time, an in vitro model (human corneal epithelial cells). Finally, we were interested intargeting genes regulation by atRA in the ocular sphere, specially known to be implied in theECM dynamic.First, we demonstrated that atRA improves corneal epithelium wound healing, essentially byacting on migration. Then, we identified a gene, LOXL4, member of the lysyl oxidase family,which expression is induced by atRA and we proved that this one is essential in cornealwound healing, describing for the first time a direct gene and protein link between vitamin A,active substance, and its clinical pro-healing action.

No description available.

The conventional view for corneal epithelial maintenance suggests that a stem cell population found in the limbus (at the rim of the cornea) produces daughter cells, called transient amplifying cells, which migrate centripetally. This limbal stem cell (LSC) hypothesis was recently questioned and the alternative model suggests that stem cells are present throughout the corneal epithelium. The main aims of this thesis were to investigate whether age and Pax6 genotype affect LSC function. Previous work with X-inactivation mosaics revealed radial stripes of β-galactosidase-expressing cells in the corneal epithelium (from about 5 weeks of age), which decreased with age and were reduced in Pax6+/- mice (a model for aniridia, a human eye disease). The reduction in Pax6+/- mice could be due to either reduced LSCs function or a more coarse-grained mosaicism caused by reduced cell mixing during development. Comparison of patch sizes in Pax6+/- and wild-type X-inactivation mosaics showed that patches were smaller in Pax6+/- cornea epithelia before the initiation of stripes (3 weeks of age). This implies that stripe-number reduction is not caused by reduced cell mixing, so an effect on LSC function remained a possibility. Thus, the numbers of label-retaining cells (putative stem cells) in Pax6+/- were compared to controls at 15 and 30 weeks old but they were not reduced at 30 weeks or in Pax6+/- mice, as had been predicted. The failure to demonstrate the predicted result suggests either that the hypothesis was incorrect or the experimental approach was inappropriate. Furthermore, it was discovered that mice expressing β-galactosidase under the keratin 5 promoter produced rare stripes in the corneal epithelium, which are likely to represent clonal lineages derived from individual stem cells. Older mice demonstrated a significantly lower frequency of stripes, a result compatible with the predicted reduction of active LSC with age. Pax6+/- corneas were highly abnormal and stripes were not formed properly, so direct comparison was not possible. Finally, pilot experiments with conditional expression of a reporter gene revealed the successful formation of a stripe, and hence provide a plausible alternative approach to compare stripe numbers reflecting active LSCs but the method has yet to be optimised. Overall, the results suggest that LSCs are reduced with age and support the limbal location of stem cells maintaining the corneal epithelium.

Doenças da córnea estão entre as principais causas de cegueira e os mecanismos de lesão e reparação estão em grande parte concentradas no epitélio, porém os mediadores e alvos para possíveis intervenções terapêuticas são pouco conhecidos.Nas agressões ao epitélio da córnea, a ativação dos receptores vanilóides de potencial transitório 1 (TRPV1) leva a resposta inflamatória e cicatricial. O objetivo desse trabalho é identificar os mecanismos de sinalização e resposta do TRPV1 na córnea de animais experimentais. O cultivo de células epiteliais de córnea de ratos, a identificação de mediadores por western blot, medida do influxo de cálcio, resposta de citocinas medidas por ensaio quantitativo de PCR em tempo real (RNAm) e ELISA (proteína) após estímulos nocioceptivos ou inflamatórios; e a investigação histológica e imunohistoquimica em modelos animais, sejam ratos com diabetes mellitus (DM) por 8 semanas ou expostos a cloreto de benzalcônio a 0,2% (BAC) por 7 dias. Camundongos TRPV1-/- comparados aos controles C57 foram comparados sem estimulo, ou sob estimulo único com CAP a 1µM, BAC 0,2 % por 7 dias ou após queimadura alcalina com NaOH a 1M. Os resultados mostraram a presença de TRPV1 em epitélio de córnea em cultura primária, mostraram que essas células respondem com influxo de cálcio ao estímulo com o agonista Capsaicina a 1µM e aumento de TNF? e IL-1? (sendo máximo nas combinações CAP+CPZ e Win+CAP, respectivamente). Em ratos com DM e BAC ocorre a redução da expressão do RNAm de IL-1? (p=0,0269) na córnea, entre outras alterações. Os camundongos TRPV1-/- tem fenótipo físico e ocular normal, porém reduzida sensibilidade a CAP 1µM. O tratamento com BAC leva a diminuição da secreção lacrimal (p=0,0011) e de IL-1? e TNF? na glândula lacrimal (GL) de TRPV1-/- machos (p=0,0177, p=0,0245, respectivamente). A queimadura alcalina com NaOH 1M resultou em melhor cicatrização e maior espessura epitelial no grupo TRPV1-/-. Em ix conclusão, o TRPV1 está presente na córnea e atua em resposta a agressões externas. Situações adquiridas como DM e toxicidade por BAC, reconhecidas como neuropáticas diminuem a expressão de mediadores inflamatórios. A ausência genética e TRPV1 não altera o fenótipo, mas apresenta menor sensibilidade e melhor restauração da superfície ocular após queimadura alcalina / Corneal diseases are among the leading causes of blindness.Damage and repair mechanisms are largely concentrated in the epithelium, but the mediators and targets for possible therapeutic interventions are poorly understood. The aggressions to the corneal epithelium, the activation of vanilloid receptors transient potential 1 (TRPV1) leads to inflammatory and wound healing. The aim of this study is to identify the signaling mechanisms and TRPV1 response in the cornea of experimental animals.The culture of epithelial cells from rat cornea, to identify mediators by western blot analysis, measurement of calcium influx, cytokine response measured by PCR real time (mRNA) and ELISA (protein) nocioceptivos or after inflammatory stimuli; and the histological and immunohistochemical investigation in animal models are mice with diabetes mellitus (DM) for 8 weeks, and exposed to benzalkonium chloride at 0.2% (BAC) for 7 days. Mice TRPV1-/- compared to control C57 were compared with no stimulus, or under single stimulation with 1 µM Capsaicine (CAP), BAC 0.2% for 7 days or after the alkali burn with NaOH 1 M.The results showed the presence of TRPV1 in corneal epithelium in primary culture, showed that these cells respond to calcium influx the stimulus with capsaicin agonist 1?M and increase of TNF? and IL-1? (being maximum at the CAP + CPZ combinations and Win + CAP, respectively). In rats with DM and BAC occurs reducing the expression of IL-1? mRNA (p = 0.0269) in the cornea, among other changes. The TRPV1-/- mice have physical phenotype and normal ocular but low sensitivity to CAP 1?M. Treatment with BAC leads to decreased tear secretion (p = 0.0011) and IL-1? and TNF? in the lacrimal gland (GL) of TRPV1-/- mice (p = 0.0177, p = 0.0245, respectively) . The alkaline burn with NaOH 1M resulted in better healing and greater epithelial thickness in TRPV1-/- group .In conclusion, TRPV1 is present in the cornea and operates in response to external aggressions. Situations existing as DM and xi toxicity BAC recognized as neuropathic decrease the expression of inflammatory mediators. Genetic absence and TRPV1 does not alter the phenotype, but has lower sensitivity and better restoration of the ocular surface after alkaline burn

Doenças da córnea estão entre as principais causas de cegueira e os mecanismos de lesão e reparação estão em grande parte concentradas no epitélio, porém os mediadores e alvos para possíveis intervenções terapêuticas são pouco conhecidos.Nas agressões ao epitélio da córnea, a ativação dos receptores vanilóides de potencial transitório 1 (TRPV1) leva a resposta inflamatória e cicatricial. O objetivo desse trabalho é identificar os mecanismos de sinalização e resposta do TRPV1 na córnea de animais experimentais. O cultivo de células epiteliais de córnea de ratos, a identificação de mediadores por western blot, medida do influxo de cálcio, resposta de citocinas medidas por ensaio quantitativo de PCR em tempo real (RNAm) e ELISA (proteína) após estímulos nocioceptivos ou inflamatórios; e a investigação histológica e imunohistoquimica em modelos animais, sejam ratos com diabetes mellitus (DM) por 8 semanas ou expostos a cloreto de benzalcônio a 0,2% (BAC) por 7 dias. Camundongos TRPV1-/- comparados aos controles C57 foram comparados sem estimulo, ou sob estimulo único com CAP a 1µM, BAC 0,2 % por 7 dias ou após queimadura alcalina com NaOH a 1M. Os resultados mostraram a presença de TRPV1 em epitélio de córnea em cultura primária, mostraram que essas células respondem com influxo de cálcio ao estímulo com o agonista Capsaicina a 1µM e aumento de TNF? e IL-1? (sendo máximo nas combinações CAP+CPZ e Win+CAP, respectivamente). Em ratos com DM e BAC ocorre a redução da expressão do RNAm de IL-1? (p=0,0269) na córnea, entre outras alterações. Os camundongos TRPV1-/- tem fenótipo físico e ocular normal, porém reduzida sensibilidade a CAP 1µM. O tratamento com BAC leva a diminuição da secreção lacrimal (p=0,0011) e de IL-1? e TNF? na glândula lacrimal (GL) de TRPV1-/- machos (p=0,0177, p=0,0245, respectivamente). A queimadura alcalina com NaOH 1M resultou em melhor cicatrização e maior espessura epitelial no grupo TRPV1-/-. Em ix conclusão, o TRPV1 está presente na córnea e atua em resposta a agressões externas. Situações adquiridas como DM e toxicidade por BAC, reconhecidas como neuropáticas diminuem a expressão de mediadores inflamatórios. A ausência genética e TRPV1 não altera o fenótipo, mas apresenta menor sensibilidade e melhor restauração da superfície ocular após queimadura alcalina / Corneal diseases are among the leading causes of blindness.Damage and repair mechanisms are largely concentrated in the epithelium, but the mediators and targets for possible therapeutic interventions are poorly understood. The aggressions to the corneal epithelium, the activation of vanilloid receptors transient potential 1 (TRPV1) leads to inflammatory and wound healing. The aim of this study is to identify the signaling mechanisms and TRPV1 response in the cornea of experimental animals.The culture of epithelial cells from rat cornea, to identify mediators by western blot analysis, measurement of calcium influx, cytokine response measured by PCR real time (mRNA) and ELISA (protein) nocioceptivos or after inflammatory stimuli; and the histological and immunohistochemical investigation in animal models are mice with diabetes mellitus (DM) for 8 weeks, and exposed to benzalkonium chloride at 0.2% (BAC) for 7 days. Mice TRPV1-/- compared to control C57 were compared with no stimulus, or under single stimulation with 1 µM Capsaicine (CAP), BAC 0.2% for 7 days or after the alkali burn with NaOH 1 M.The results showed the presence of TRPV1 in corneal epithelium in primary culture, showed that these cells respond to calcium influx the stimulus with capsaicin agonist 1?M and increase of TNF? and IL-1? (being maximum at the CAP + CPZ combinations and Win + CAP, respectively). In rats with DM and BAC occurs reducing the expression of IL-1? mRNA (p = 0.0269) in the cornea, among other changes. The TRPV1-/- mice have physical phenotype and normal ocular but low sensitivity to CAP 1?M. Treatment with BAC leads to decreased tear secretion (p = 0.0011) and IL-1? and TNF? in the lacrimal gland (GL) of TRPV1-/- mice (p = 0.0177, p = 0.0245, respectively) . The alkaline burn with NaOH 1M resulted in better healing and greater epithelial thickness in TRPV1-/- group .In conclusion, TRPV1 is present in the cornea and operates in response to external aggressions. Situations existing as DM and xi toxicity BAC recognized as neuropathic decrease the expression of inflammatory mediators. Genetic absence and TRPV1 does not alter the phenotype, but has lower sensitivity and better restoration of the ocular surface after alkaline burn

De par son rôle dans de nombreuses fonctions biologiques, RAGE est une récepteur membranaire crucial du développement embryonnaire jusqu’à l’âge adulte. Ce récepteur multi-ligand est capable d’activer de nombreuses cascades de signalisation, lui permettant entre autres d’être impliqué dans les processus inflammatoires et cicatriciels. Bien que décrite, son action cellulaire et moléculaire dans les processus de régénération/cicatrisation reste encore à éclaircir, malgré des études déjà menées sur les épithéliums cutanée et pulmonaire. Concernant la cicatrisation de l’épithélium cornéen, l’action de ce récepteur et de ses ligands est peu documentée et largement controversé. Ce travail a permis de tester l’effet de 2 ligands de RAGE (HMGB1 et AGEs) sur la cicatrisation de l’épithélium cornéen en utilisant un modèle in vitro de cellules épithéliales de cornée humaine (HCE). Il visait aussi à étudier les cascades de signalisation et les processus cellulaire mis en jeu suite à l’activation de ce récepteur. Les résultats obtenus ont tout d’abord permis de démontrer que l’action pro-cicatrisante du récepteur RAGE sur des cellules de l’épithélium cornéen, était ligand et dose spécifique. Ainsi seul le ligand AGEs promeut la cicatrisation indépendamment des processus de migration et de prolifération cellulaire. Dans cette étude le couple AGEs/RAGE est capable d’activer la cascade de signalisation NF-κB et la transcription d’un gène cible Connexine 43, dont le rôle a déjà été décrit durant la cicatrisation.Malgré la complexité du « signal RAGE », les premières pistes apportées par cette étude permettent d’envisager dans un futur proche la caractérisation précise de son action pro-cicatrisante au niveau de la sphère oculaire. Ceci passera non seulement par l’étude exhaustive des cascades de signalisations activées et des gènes régulés mais aussi par l’utilisation du modèle animal souris sauvage et RAGE -/-. / Because of its role in many biological functions, RAGE is a crucial transmembranous receptor from development to adulthood. This multiligand receptor can activate numerous signaling pathways, and it is involved in inflammatory and wound healing processes. Although already describe, molecular and cellular processes involved during wound healing still to be clarify despite some studies conducted on skin and lung epithelium. In the corneal epithelium wound healing, RAGE and its ligands effects still poorly understood and widely controversial. This work allowed the test of 2 ligands (HMGB1 and AGEs) on corneal epithelium healing using an in-vitro model of human corneal epithelial cells (HCE). It also aims to study the signaling pathways and cellular processes involved after this receptor activation. Results obtained permit to demonstrate a ligand and dose-dependent action of RAGE during this pro-healing process. Thus, only AGEs ligand promotes wound healing independently of cellular migration and proliferation processes. In this study, AGEs/RAGE couple can activate NF-kB signaling pathway and Connexin 43 target gene expression, already describe to be involved in wound healing. Despite the “RAGE signal” complexity, first tracks brought by this study allow to plan in the near future the precise elucidation of its pro-healing properties in the ocular sphere. This will pass not only by the exhaustive study of the signaling pathways activated and the regulated genes but also by the use of wild-type and RAGE - / - mouse model.

La greffe de Membrane Amniotique Humaine (MAH) permet la cicatrisation des ulcères pré-perforants de la cornée et de sauver un nombre significatif d'yeux victimes de brûlures chimiques. La MAH est un matériel biologique, son utilisation pour le traitement des maladies de la surface oculaire donne de bons résultats en raison de sa capacité à réduire l'inflammation et promouvoir une épithélialisation rapide. Pour son utilisation en clinique, la MAH doit bien évidemment être stérile, mais aussi facile à transporter du centre préleveur au centre greffeur, et stockable longtemps et facilement. Actuellement en routine à la banque de tissus de Rouen, la membrane amniotique est séparée de l’amnios puis dénudée de leur couche spongieuse. Par la suite cette membrane est conservée par cryopréservation (congélation à –80°C) ce qui complique potentiellement l’acheminement des membranes. Par conséquent, dans le cadre de cette étude avec la Banque Normande de Cornées du CHU de Rouen nous avons développé la lyophilisation des MAH pour faciliter son utilisation et sa distribution. L’étude du mapping de la MAH permettra également de déterminer si le taux de facteurs de croissance est homogène dans la MAH ou s’il dépend sa distance par rapport au cordon ombilical. L’étude de la biocompatibilité in vivo d’un deuxième matériau composé de collagène nous permet également d’envisager une alternative pour une implantation du stroma. Nos analyses protéiques (ELISA et Label-free) des MAH la lyophilisées ne montrent pas de différence significative en terme de quantité et de qualité protéique. L’approche protéomique est complétée par l’analyse de la capacité des cellules épithéliales de cornée humaines (CEC) à se multiplier sur la membrane amniotique lyophilisée in vitro. Nous n’avons pas observé de différence entre la croissance des cellules épithéliales sur la MAH lyophilisée ou congelée. L’analyse du total de protéines extraites montre également que la lyophilisation ne dégrade pas les MAH au niveau protéique.Au niveau structurel les résultats de la microscopie électronique ont montré que la structure du stroma de la MAH est impactée par la lyophilisation. La greffe des MAH a été réalisée sur les ulcères cornéens chez le lapin. Au cours de l’expérimentation les lapins n’ont pas montré de signe d’inflammation, les analyses histologiques ont mis en évidence l’épithélialisation de la surface oculaire. Ce projet est en collaboration avec l‘association ophtalmo sans frontière pour qu’à terme le développement de l’utilisation clinique des MAHL répondant notamment à des besoins humanitaires (Cameroun). Notre étude de la cartographie de la MAH a également montré qu’une variabilité en termes de quantité de protéine existe entre les différents donneurs. Dans cette étude nous avons également montré que la couche spongieuse est une source de facteurs de croissance importante dans le processus de cicatrisation des ulcères cornéens. / The Human Amniotic Membrane (HAM) graft allows the healing of corneal ulcers and rescues a significant number of eyes with chemical burn. HAM is a biological material, its use for the treatment of ocular surface diseases gives good results because of its ability to reduce inflammation and promote rapid epithelialization. For its clinical use, the HAM must of course be sterile, but also easy to transport from the sampling center to the transplant center, and easily storable and for a long time. Currently on routine in the tissue bank of Rouen, the amniotic membrane is separated from the amnion and denuded of its spongy layer. Subsequently this membrane is stored by cryopreservation (freezing at -80 ° C) which potentially complicates the delivery of membranes. Consequently, as part of this study with the Banque Normande de Cornées of Rouen University Hospital, we have developed freeze-drying of HAM to facilitate its use and distribution. The HAM mapping study will also determine whether the level of growth factors is homogeneous in the HAM or whether it depends on its distance from the umbilical cord. The study of the in vivo biocompatibility of a second material composed of collagen also allows us to consider an alternative for implantation at the level of the stroma. Our protein analyzes (ELISA and Label-free) of freeze-dried HAM do not show any significant difference in terms of quantity and protein quality. The proteomic approach is complemented by the analysis of the ability of human corneal epithelial cells (CECs) to multiply on the freeze-dried amniotic membrane in vitro. We did not observe any difference between the epithelial cells growths on freeze-dried or frozen HAM. The analysis of the extracted protein total also shows that freeze-drying does not degrade the HAM at the protein level. At the structural level the electron microscopy results showed that the structure of the MAH stroma is impacted by freeze-drying. The MAH transplant performed on corneal ulcers in rabbits was performed. During the experiment the rabbits did not show any sign of inflammation, the histological analyzes highlighted the epithelialization of the ocular surface.This project is in collaboration with OSF association for the development of the clinical use of MAHL responding in particular to humanitarian needs (Cameroon). Our study of HAM mapping also showed that variability in terms of amount of protein exists between different donors. We have also shown that the spongy layer is an important source of important growth factor in the healing process of corneal ulcers.